In particular, the alarmin S100A9, the levels of which were shown to be elevated in low-risk MDS [25,26], appears to play a pivotal role in triggering NLRP3 inflammasome activation and propagation of the dysplastic clone [24,27]. The gene discussed is S100A9; the disease is myelodysplastic syndrome.